| A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns MA Ghannoum, RA Hajjeh, R Scher, N Konnikov, AK Gupta, ... Journal of the American Academy of Dermatology 43 (4), 641-648, 2000 | 721 | 2000 |
| Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis P Rich, RK Scher Journal of the American Academy of Dermatology 49 (2), 206-212, 2003 | 668 | 2003 |
| Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey AK Gupta, N Konnikov, P MacDonald, P Rich, N Rodger, MW Edmonds, ... British Journal of Dermatology 139 (4), 665-671, 1998 | 540 | 1998 |
| Secukinumab induction and maintenance therapy in moderate‐to‐severe plaque psoriasis: a randomized, double‐blind, placebo‐controlled, phase II regimen‐finding study P Rich, B Sigurgeirsson, D Thaci, JP Ortonne, C Paul, RE Schopf, ... British Journal of Dermatology 168 (2), 402-411, 2013 | 386 | 2013 |
| Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study JK Geisse, P Rich, A Pandya, K Gross, K Andres, A Ginkel, M Owens Journal of the American Academy of Dermatology 47 (3), 390-398, 2002 | 340 | 2002 |
| Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies BE Elewski, P Rich, R Pollak, DM Pariser, S Watanabe, H Senda, C Ieda, ... Journal of the American Academy of Dermatology 68 (4), 600-608, 2013 | 316 | 2013 |
| Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea JQ Del Rosso, GF Webster, M Jackson, M Rendon, P Rich, H Torok, ... Journal of the American Academy of Dermatology 56 (5), 791-802, 2007 | 311 | 2007 |
| Efficacy and safety of a new triple-combination agent for the treatment of facial melasma SC Taylor, H Torok, T Jones, N Lowe, P Rich, E Tschen, A Menter, ... CUTIS-NEW YORK- 72 (1), 67-73, 2003 | 264 | 2003 |
| The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis. SE Cassell, JD Bieber, P Rich, ZN Tutuncu, SJ Lee, KC Kalunian, CW Wu, ... The Journal of rheumatology 34 (1), 123-129, 2007 | 257 | 2007 |
| A new classification system for grading the severity of onychomycosis: Onychomycosis Severity Index C Carney, A Tosti, R Daniel, R Scher, P Rich, J DeCoster, B Elewski Archives of dermatology 147 (11), 1277-1282, 2011 | 235 | 2011 |
| Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year P Rich, CEM Griffiths, K Reich, FO Nestle, RK Scher, S Li, S Xu, MC Hsu, ... Journal of the American Academy of Dermatology 58 (2), 224-231, 2008 | 233 | 2008 |
| Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program … B Strober, D Thaçi, H Sofen, L Kircik, KB Gordon, P Foley, P Rich, C Paul, ... Journal of the American Academy of Dermatology 88 (1), 40-51, 2023 | 228 | 2023 |
| Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: results from 2 randomized phase-III … BE Elewski, R Aly, SL Baldwin, RFG Soto, P Rich, M Weisfeld, H Wiltz, ... Journal of the American Academy of Dermatology 73 (1), 62-69, 2015 | 212 | 2015 |
| Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: results of 2 phase III randomized, controlled trials (ESTEEM 1 … P Rich, M Gooderham, H Bachelez, J Goncalves, RM Day, R Chen, ... Journal of the American Academy of Dermatology 74 (1), 134-142, 2016 | 172 | 2016 |
| Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail RK Scher, D Breneman, P Rich, RC Savin, DS Feingold, N Konnikov, ... Journal of the American Academy of Dermatology 38 (6), S77-S86, 1998 | 161 | 1998 |
| Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: a dermatologist and nail expert group consensus D Rigopoulos, R Baran, S Chiheb, CR Daniel III, N Di Chiacchio, ... Journal of the American Academy of Dermatology 81 (1), 228-240, 2019 | 153 | 2019 |
| Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma HM Torok, T Jones, P Rich, S Smith, E Tschen Cutis 75 (1), 57-62, 2005 | 146 | 2005 |
| Ustekinumab improves nail disease in patients with moderate‐to‐severe psoriasis: results from PHOENIX 1 P Rich, M Bourcier, H Sofen, S Fakharzadeh, Y Wasfi, Y Wang, ... British Journal of Dermatology 170 (2), 398-407, 2014 | 138 | 2014 |
| Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies P Foley, M Freeman, A Menter, G Siller, RA El‐Azhary, K Gebauer, ... International journal of dermatology 48 (11), 1236-1245, 2009 | 131 | 2009 |
| The epidemiology, etiology, and pathophysiology of onychomycosis RK Scher, P Rich, D Pariser, B Elewski , 32 32 (2), 2-4, 2013 | 126 | 2013 |
